Aurélie Cointe

Dr. Aurélie Cointe

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2020 in Toxins
Verified
Journal Article
Open access
PDF file
AJAdrien JOSEPH
Adrien JOSEPH
ACAurélie Cointe
Aurélie Cointe
PKPatricia Mariani Kurkdjian
Patricia Mariani Kurkdjian
CRCédric Rafat
Cédric Rafat
AHAlexandre Hertig
Alexandre Hertig
The severity of human infection by one of the many Shiga toxin-producing Escherichia coli (STEC) is determined by a number of factors: the bacterial genome, the capacity of human societies to prevent foodborne epidemics, the medical condition of infected patients (in particular their hydration status, often compromised by severe diarrhea), and by our capacity to devise new therapeutic approaches, most specifically to combat the bacterial virulence factors, as opposed to our current strategies that essentially aim to palliate organ deficiencies. The last major outbreak in 2011 in Germany, which killed more than 50 people in Europe, was evidence that an effective treatment was still lacking. Herein, we review the current knowledge of STEC virulence, how societies organize the prevention of human disease, and how physicians treat (and, hopefully, will treat) its potentially fatal complications. In particular, we focus on STEC-induced hemolytic and uremic syndrome (HUS), where the intrusion of toxins inside endothelial cells results in massive cell death, activation of the coagulation within capillaries, and eventually organ failure.

26 April 2021 in Toxins
Verified
Journal Article
Open access
PDF file
BTBenoit Travert
Benoit Travert
CRCédric Rafat
Cédric Rafat
PMPatricia Mariani
Patricia Mariani
ACAurélie Cointe
Aurélie Cointe
ADAntoine DOSSIER
Antoine DOSSIER
AJAdrien JOSEPH
Adrien JOSEPH
Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome (STEC-HUS) is a form of thrombotic microangiopathy secondary to an infection by an enterohemorrhagic E. coli. Historically considered a pediatric disease, its presentation has been described as typical, with bloody diarrhea at the forefront. However, in adults, the clinical presentation is more diverse and makes the early diagnosis hazardous. In this review, we review the epidemiology, most important outbreaks, physiopathology, clinical presentation and prognosis of STEC-HUS, focusing on the differential features between pediatric and adult disease. We show that the clinical presentation of STEC-HUS in adults is far from typical and marked by the prevalence of neurological symptoms and a poorer prognosis. Of note, we highlight knowledge gaps and the need for studies dedicated to adult patients. The differences between pediatric and adult patients have implications for the treatment of this disease, which remains a public health threat and lack a specific treatment.

1 December 2020 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
ACAurélie Cointe
Aurélie Cointe
ABAndré Birgy
André Birgy
APAlice Pascault
Alice Pascault
FLFerielle Louillet
Ferielle Louillet
ADAlice Dufougeray
Alice Dufougeray
SBStéphane Bonacorsi
Stéphane Bonacorsi

26 September 2021 in Toxins
Verified
Journal Article
Open access
PDF file
ACAurélie Cointe
Aurélie Cointe
EBEtienne BIZOT
Etienne BIZOT
SDSabine Delannoy
Sabine Delannoy
PFPatrick FACH
Patrick FACH
PBPhilippe Bidet
Philippe Bidet
SBStéphane Bonacorsi
Stéphane Bonacorsi
O80:H2 enterohemorrhagic Escherichia coli (EHEC) of sequence type ST301 is one of the main serotypes causing European hemolytic and uremic syndrome, but also invasive infections, due to extra-intestinal virulence factors (VFs). Here, we determined whether other such heteropathotypes exist among ST301. EnteroBase was screened for ST301 strains that were included in a general SNP-phylogeny. French strains belonging to a new heteropathotype clone were sequenced. ST, hierarchical clusters (HC), serotype, resistome, and virulome were determined using EnteroBase, the CGE website, and local BLAST. The ST301 general phylogeny shows two groups. Group A (n = 25) is mainly composed of enteropathogenic E. coli, whereas group B (n = 55) includes mostly EHEC. Three serotypes, O186:H2, O45:H2 and O55:H9, share the same virulome as one of the O80:H2 sub-clones from which they derive subsequent O-antigen switches. The O55:H9 clone, mainly present in France (n = 29), as well as in the UK (n = 5) and Germany (n = 1), has a low background of genetic diversity (four HC20), although it has three Stx subtypes, an H-antigen switch, and genes encoding the major extra-intestinal VF yersiniabactin, and extended-spectrum beta-lactamases. Diverse heteropathotype clones genetically close to the O80:H2 clone are present among the ST301, requiring close European monitoring, especially the virulent O55:H9 clone.

1 April 2019 in Anaerobe
Verified
Journal Article
Closed access
ACAurélie Cointe
Aurélie Cointe
GPGauthier Péan de Ponfilly
Gauthier Péan de Ponfilly
AMAnne-Lise Munier
Anne-Lise Munier
MBMarwa Bachir
Marwa Bachir
HBHanaa Benmansour
Hanaa Benmansour
HJHervé Jacquier
Hervé Jacquier

Verified
Journal Article
Open access
PDF file
NSNathan SOLEAU
Nathan SOLEAU
SGSarah GANET
Sarah GANET
SWStéphanie Werlen
Stéphanie Werlen
LCLia Collignon
Lia Collignon
ACAurélie Cointe
Aurélie Cointe
DSDelphine Sergentet
Delphine Sergentet
The emerging heteropathotype shigatoxigenic (STEC) and extra-intestinal pathogenic Escherichia coli (ExPEC) O80:H2 has been the second leading cause of pediatric HUS in France since the mid-2010s. In contrast with other highly pathogenic STEC serotypes, for which ruminants have clearly been identified as the main human infection source, this heteropathotype’s reservoir remains unknown. In this context, we describe for the first time the isolation of seven STEC O80:H2 strains from healthy cattle on a single cattle farm in France. This study aimed at (i) characterizing the genome and (ii) investigating the phylogenetic positions of these O80:H2 STEC strains. The virulomes, resistomes, and phylogenetic positions of the seven bovine isolates were investigated using in silico typing tools, antimicrobial susceptibility testing and cgMLST analysis after short-read whole genome sequencing (WGS). One representative isolate (A13P112V1) was also subjected to long-read sequencing. The seven isolates possessed ExPEC-related virulence genes on a pR444_A-like mosaic plasmid, previously described in strain RDEx444 and known to confer multi-drug resistance. All isolates were clonally related and clustered with human clinical strains from France and Switzerland with a range of locus differences of only one to five. In conclusion, our findings suggest that healthy cattle in France could potentially act as a reservoir of the STEC-ExPEC O80:H2 pathotype.